polycystic ovaries (PCO)
EFFECT OF FENUGREEK AND PALM POLLEN EXTRACT ON INDUCED POLYCYSTIC OVARIES IN FEMALE RATS
... of polycystic ovaries (PCO) in 15 female rats Lalithamma and Changamma, (2013), Farideh et ...the PCO-induced rats were not any subjected to any other treatment and served as the negative ...
16
ENVIRONMENTAL FACTORS AND POLYCYSTIC OVARIES
... transducer. Polycystic ovaries were diag nosed using Adam's criteria,S namely the presence of 1 0 or more peripheral small ...normal ovaries (n= 40) and a group of sub jects with scan evidence of ...
6
Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement
... for polycystic ovaries exclude an assessment of follicle pattern, the appropriate- ness of its omission as a diagnostic criterion is questiona- ...diagnosing polycystic ovaries ...
9
Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries
... of polycystic ovaries are ...a polycystic ovary where an apparently 'even' distribution of follicles is evident at the end of the ovary while a peripheral distribution of follicles is evident at the ...
11
Impaired carotid viscoelastic properties in women with polycystic ovaries
... In summary, our results provide additional evidence of significant vascular dysfunction in women with polycystic ovaries and highlight the need to confirm or refute the present discrepancy between ...
6
Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system
... rat PCO model used in this study significantly reduced increased concentrations of ovarian NGF and of median eminence (ME) corticotro- pin-releasing factor (CRF) [13,14], which indicates a func- tional interaction ...
8
Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro
... rat ovaries from hormone-treated animals with different follicular developmental stages and in those from rats with PCOs after androstenedione ...control ovaries had mostly primordial and primary follicles ...
12
A COMPREHENSIVE OVER VIEW OF POLYCYSTIC OVARIAN SYNDROME (PCOS)
... consistencies between the criteria offered by the different groups, important differences exist. Each issuing group considers PCOS a diagnosis of exclusion, and other diagnoses, such as congenital adrenal hyperplasia, ...
12
The effects of factors influencing human oocyte maturation upon fertilization and preimplantation embryo development
... Immature oocytes were either collected from unstimulated patients with polycystic ovaries PCO during gynaecological surgery, or were donated by patients undergoing a cycle of intracytopl[r] ...
297
LETROZOLE AND FRUCTOSE INDUCED POLYCYSTIC OVARIES IN THE RAT: A NOVEL MODEL EXHIBITING BOTH OVARIAN AND METABOLIC CHARACTERISTICS FOR POLYCYSTIC OVARY SYNDROME IN RAT
... for polycystic ovary syndrome (PCOS), a fully convincing model for PCOS reflecting all pathologic condition of PCOS seen in humans is not available due to difficulties in inducing all pathologies in rat ...assays. ...
6
The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM
... on polycystic ovaries may reside in de- struction of small antral and pre-antral follicles, besides stroma, resulting in a relatively long term impact on cir- culating levels of AMH, LH, and total and free ...
6
Vanishing large ovarian cyst with thyroxine therapy
... the polycystic ovary syndrome-like appearance, together with improve- ment in serum hormone levels, has been shown to occur after the achievement of euthyroidism ...Although polycystic ovaries are ...
5
Vol 30, No 1 (2020)
... non-acne patients. The 95% CI was (1.084 to 4.320) as this limit not included one its means that this variable was significant with the disease and positively associated with the hirsute. For next variable PCOS (1) ...
8
Original Article Activation of NLRP3 inflammasome in the ovaries during the development and treatment of polycystic ovary syndrome
... itor can cause ovulatory failure and polycystic ovaries [22]. The present study established this letrozole-induced PCOS rat model by confirm- ing the ovarian histology and follicular struc- ture. Chronic ...
9
Investigating the mechanisms of endometrial cancer risk in polycystic ovary syndrome: can UK biobank help?
... Table 2, illustrates the prevalence of gynaecology and early pregnancy problems reported by women recruited into UK biobank (self-reported diagnosis). A total of 643 (0.23%) women reported having polycystic ...
7
The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
... Our study does have some limitations; we did not use the menstrual diary to identify menstrual intervals and we did not measure progesterone to identify eumenor- rheic women, who had subclinical menstrual dysfunc- tion; ...
7
AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
... available. Polycystic Ovary Syndrome (PCOS) is an endocrine metabolic disorder characterized by multiple hormonal imbalances representing diverse clinical presentations dominated by clinical and biochemical signs ...
9
The role of vascular endothelial growth factor (VEGF) in physiology and pathology of reproductive function
... The important findings of this study are that women with polycystic ovaries have higher serum concentrations of vascular endothelial growth factor (VEGF) and highe[r] ...
295
The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta analysis
... Polycystic ovary syndrome (PCOS) is the most common endocrinopathy, with 4 – 12% of reproductive-aged women affected [1]. The typically used diagnostic criteria in the UK are the Rotterdam Criteria, which resulted ...
7
Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome
... and polycystic ovaries; Group B = hyperandrogenism and ovulatory dysfunction but normal ovaries; Group C = hyperandrogenism and polycystic ovaries but ovulatory cycles; Group D = ...
7